Results per Page:
Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita
Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
Fred Hutch statement on shifting most on-site lab and clinical research to remote work
Scientists will continue producing life-saving research while limiting on-site work to prevent the spread of COVID-19
Tracking the coronavirus epidemic from Wuhan to the world
Scientists and public health officials worldwide collaborate to understand COVID-19 and slow its spread
Zika virus: 6 key things we don’t yet know
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
Fred Hutchinson Cancer Research Center designated MIDAS Center of Excellence
Designation puts Fred Hutch on cutting edge of U.S. analysis and response to infectious disease outbreaks around the globe - Center includes researchers from seven other academic sites across the country
Oral vaccine could have halved Haiti’s cholera epidemic
VIDD study shows need for comprehensive global action plan, strategy to reduce cholera-related mortality in developing countries
Study finds mass vaccination unnecessary in the event of a large-scale bioterrorist smallpox attack in the United States
Prompt surveillance and containment of victims would effectively thwart an epidemic